Sector portfolio · VC firm · United States
Sofinnova Investments' Biotech portfolio
Sofinnova Investments has backed 37 Biotech startups in rounds we track, $3.4B between them, shown by the stage each has reached. The best-funded is Star Therapeutics.
37startups backed
4stages
$3.4Braised between them
Series Bbiggest stage
Series B
13
Funding by segment
- Series B$1.1B13
- Series C and later$1.7B13
- Series A$263M6
- Stage not reported$351M5
Where they are based
- United States31$3.1B
- France3$147M
- Austria1$97M
United States
France
AustriaFounded
12Earlier
212
13
314
315
16
217
118
119
20
121
22
23
24
25
26
12 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M2
- $10M to $50M10
- $50M to $250M23
- $250M to $1B2
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
25 of 37 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States31
- France3
- Austria1
Startups by country, 3 countries in all.
Segment by segment
Series B
13 startups · $1.1B raised
- CTCity TherapeuticsUnited States$235M
Galera TherapeuticsGalera Therapeutics develops therapeutic agents for preventing damage to normal tissues during the radiation treatment of cancer.United States$219M- CTCapstan TherapeuticsCapstan Therapeutics is advancing cell engineering to develop therapeutics for a broad range of diseases.United States$175M
SARcode BioscienceSARcode Bioscience develops an antigen for the treatment of unmet medical needs in ophthalmology, dermatology and inflammatory diseases.United States$98M
Checkmate PharmaceuticalsCheckmate Pharma is a clinical stage biopharmaceutical company developing a new approach for cancer immunotherapy.United States$69M
DNA ScriptDNA Script is a disruptive DNA synthesis company harnessing biology to accelerate breakthroughs in life science and human health.France$62M- CCorvidiaCorvidia Therapeutics focuses on the research and development of transformative therapies for cardio-renal diseases.United States$61M
- BTBioClin TherapeuticsUnited States$56M
Series C and later
13 startups · $1.7B raised
Star TherapeuticsStar Therapeutics is a clinical-stage biotechnology company based in South San Francisco, California, founded in 2018.United States$325M
Coherus BiosciencesCoherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.United States$299M
aTyr PharmaaTyr Pharma (Nasdaq: LIFE) is a biotherapeutics company engaged in the discovery and development of innovative medicines based on United States$181M
Atsena TherapeuticsAtsena Therapeutics is a clinical-stage gene therapy company based in Durham, North Carolina, focused on developing treatments forUnited States$150M
HotSpot TherapeuticsHotSpot Therapeutics is a developer of a therapy platform designed to discover medicines and provide proper treatment.United States$145M
Civitas TherapeuticsCivitas develops pulmonary delivery therapies.United States$122M- RRefleXionReflexion offers holistic fitness through Pilates and Gyrotonic exercise.United States$100M
HookipaHookipa GmbH – Private Equity, Finanzierungen, Start-Up Coaching und Vermittlung von Kontakten & Personal.Austria$97M
Series A
6 startups · $263M raised
- IPInozyme PharmaUnited States$116M
- AAkuousUnited States$50M
- LBLabrys BiologicsLabrys Biologics develops treatments for chronic migraine.-$46M
DauntlessDauntless is a Seattle-area software developer providing point-of-sale and tracking software to the cannabis industry.United States$25M- XXyloCorUnited States$17M
- IBIntrepida BioIntrepidaBio is a preclinical biotechnology company focused on developing cancer treatments through innovative drug therapies.United States$9.5M
Stage not reported
5 startups · $351M raised
- CCebixCebix is a biopharmaceutical company focused on the treatment of diabetic complications.United States$96M
Principia BioPharmaPrincipia Biopharma is dedicated to bringing oral therapies to patients with significant unmet medical needs in immunology & oncology.United States$90M- YYmAbsUnited States$80M
InteKrinInteKrin Therapeutics is focused on developing and commercializing therapeutics for neuroendocrine, metabolic and immune disorders.United States$65M- KKarunaUnited States$20M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Sofinnova Investments as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosCo-investorsWho invests with Sofinnova Investments37 co-investorsSector portfolioTechstars' AI portfolio336 startups · $4.9BSector portfolioAlumni Ventures' AI portfolio302 startups · $36BSector portfolioAndreessen Horowitz's AI portfolio259 startups · $426BSector portfolioGeneral Catalyst's AI portfolio226 startups · $179BSector portfolioSequoia Capital's AI portfolio209 startups · $543B
Raising from investors like Sofinnova Investments?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.